
Nine Summit Health Physicians Named to Connecticut Magazine's Top Doctors List
Nine physicians from Summit Health were recognized as 2025 'Top Doctors' by Connecticut Magazine. This prestigious honor demonstrates how highly regarded Summit Health's doctors are in the communities they serve and within the field of medicine. Physicians who receive this award are nominated by their peers as part of an annual survey from the healthcare organization, Castle Connolly.
'We are exceedingly proud of our physicians who were named Top Doctors and applaud them for their commitment to excellence within their fields,' said Adam Barrison, MD, Chief Physician Executive at Summit Health. 'This award is a testament to their unwavering dedication, compassion and high-quality care they provide every day, which has made a difference in the lives of so many patients.'
Congratulations to Summit Health's Top Doctors (in alphabetical order):
About Summit Health
Summit Health helps patients with their primary care and specialty care needs. Whether it's getting annual checkups, raising a family, or prioritizing healthy aging, Summit Health works as a team to deliver care that helps patients make the right choices and stay a step ahead of any issues. Exceptional doctors are committed to providing the best care and supporting patients over their lifetime. And if patients ever need urgent care, they can visit CityMD, whose providers are part of Summit Health's connected care team. To learn more, visit summithealth.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250522951908/en/
CONTACT: Media Contact:
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA CONNECTICUT NEW JERSEY
INDUSTRY KEYWORD: GENERAL HEALTH HOSPITALS HEALTH PRACTICE MANAGEMENT MANAGED CARE
SOURCE: Summit Health
Copyright Business Wire 2025.
PUB: 05/22/2025 08:49 AM/DISC: 05/22/2025 08:48 AM
http://www.businesswire.com/news/home/20250522951908/en
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
16 minutes ago
- Bloomberg
Biogen Sees Potential in Combining Alzheimer's and Obesity Drugs
If Novo Nordisk A/S 's wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer's disease, Biogen Inc.'s Chief Executive Officer Chris Viehbacher doesn't see it as a roadblock for his company's medication. Rather, he sees it as an opportunity to potentially combine drugs and create a more potent therapy. 'As we look out over the next five years, we're probably going to see a treatment much like any other complex disease,' he said in an interview with Bloomberg News, meaning there will be 'different mechanisms of action that you need.'


Fox News
an hour ago
- Fox News
Melanoma can be deadly: What to know about the disease that killed Kelly Clarkson's ex
Days after Kelly Clarkson's ex-husband, Brandon Blackstock, passed away at the age of 48, the cause of his death was revealed. On August 11, it was reported that the talent manager died after a private battle with melanoma, a form of skin cancer. "Brandon Blackstock passed away peacefully at his home in Butte, Montana on August 7 under hospice care surrounded by his family," Silver Bow County Coroner Dan Hollis told Fox News Digital. "It is with great sadness that we share the news that Brandon Blackstock has passed away. Brandon bravely battled cancer for more than three years. He passed away peacefully and was surrounded by family. We thank you for your thoughts and prayers and ask everyone to respect the family's privacy during this very difficult time." The singer, who was married to Blackstock for seven years before their divorce in 2022, reportedly "remained protective" of her ex as he battled cancer for three years. Skin cancer is the most common type of cancer in the U.S. — with one in five Americans developing the disease by the age of 70. Melanoma is the deadliest form of skin cancer, expected to take the lives of more than 8,400 people in the U.S. this year, according to the American Cancer Society. "Melanoma has a significantly higher chance of spreading than basal cell and squamous cell carcinomas, the most common types of skin cancer," said Marcus Monroe, MD, surgeon and investigator with the Huntsman Cancer Institute and associate professor at the University of Utah School of Medicine, previously told Fox News Digital. The chances of melanoma spreading to other locations increases with each stage of cancer. "For the earliest stage, this risk is estimated at less than 5%, increasing for patients with stage 2 disease to a wider range, from 5% at the low end up to 40% to 50% for the most advanced stage 2 patients," said Monroe. In stage 3 patients (those with regional spread either via in-transit metastases or to adjacent lymph nodes), up to 30% to 40% will develop distant metastases, with a 16% to 17% risk of brain metastases, the doctor added. Melanoma is the deadliest form of skin cancer, expected to take the lives of more than 8,400 people in the U.S. this year. The brain and lungs are the most common sites of metastasis for melanoma, experts confirmed. If the patient has lesions that are deep in the skin or involve the lymph nodes, the chance of melanoma spreading is higher — anywhere from 20% to 70%, according to Jose Lutzky, MD, director of cutaneous oncology services at the Sylvester Comprehensive Cancer Center in South Florida. Metastatic melanoma was once considered mostly treatment-resistant because it did not respond to traditional chemotherapy and radiation, noted Dr. Joshua Strauss from Advanced Care Oncology and Hematology Associates of the Atlantic Medical Group in Morristown, New Jersey. "Nowadays, using targeted therapies and immunotherapy survival has been dramatically improved, and there is a possibility of long-term remission with treatment," Strauss previously told Fox News Digital. Lutzky noted that melanoma is almost always curable by surgical removal when it's detected early. "Because of advances in the treatment of melanoma over the last 10 to 15 years, even very advanced melanoma can be cured in up to 50% of cases with modern immunotherapy treatment," he told Fox News Digital. "More recently, cell therapy has been approved to treat those advanced melanomas that do not respond to immunotherapy." To prevent melanoma, it's important to reduce exposure to ultraviolet radiation, especially in people with lightly pigmented skin, Strauss advised. "Sunscreen and sun-protective clothing are critical," he said. The American Academy of Dermatology recommends applying water-resistant sunscreen with broad-spectrum protection against UVA and UVB rays, and SPF 30 or higher, before sun exposure. "Indoor tanning bed use should be avoided because it is known to be associated with increased melanoma risk," Strauss added. High-risk individuals should also have yearly skin checks with a dermatologist. "This includes individuals with a personal history of skin cancer, family history of melanoma, people who take medications that suppress the immune system, and people who are highly sun-sensitive, such as those with red or blond hair, light skin pigmentation, significant freckling and light eye color," the oncologist said. For more Health articles, visit Strauss uses the acronym ABCDE to differentiate between a normal mole and a melanoma. "Moles with Asymmetry, irregular Borders, multiple Colors, Diameter larger than a pencil eraser, and Evolving or changing characteristics require further evaluation," he said. Fox News' Christina Dugan Ramirez contributed reporting.


Bloomberg
an hour ago
- Bloomberg
UK Primary Health Properties Fends Off KKR Bid for Landlord Assura
Primary Health Properties Plc has prevailed in the fiercely contested takeover battle for rival landlord Assura Plc, a watershed deal that saw shareholders reject a cash offer from private equity in favor of remaining invested in a UK public company. The transaction will create the UK's largest publicly traded health care landlord, bringing together PHP's £2.81 billion ($3.8 billion) portfolio with Assura's £3.1 billion of assets to create the country's eighth most valuable real estate investment trust by market capitalization.